Stay updated on DS-8201a in HER2 NSCLC Clinical Trial
Sign up to get notified when there's something new on the DS-8201a in HER2 NSCLC Clinical Trial page.

Latest updates to the DS-8201a in HER2 NSCLC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedAdded granular Locations listings for multiple sites (California, Colorado, Florida, Massachusetts, Michigan, Missouri, New York, Washington, Île-de-France Region, Rhne, Chiba, Osaka, Sunto-gun, Tokyo) and removed consolidated location blocks; the page revision is updated to v3.3.3.SummaryDifference1%

- Check28 days agoNo Change Detected
- Check49 days agoChange DetectedPubMed publications note updated to indicate automatic population from PubMed; revision tag updated from v3.2.0 to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedThe government funding status notice at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check71 days agoChange DetectedCore study details, eligibility criteria, outcomes, and participating locations appear unchanged; observed differences are limited to minor formatting and UI adjustments. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check100 days agoChange DetectedAdded a government-operating-status notice and a new version tag (v3.2.0); removed the old version tag (v3.1.0).SummaryDifference3%

- Check107 days agoChange DetectedPage version updated from v3.0.2 to v3.1.0; no other substantive content changes detected.SummaryDifference0.1%

Stay in the know with updates to DS-8201a in HER2 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DS-8201a in HER2 NSCLC Clinical Trial page.